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Conclusions: Metoprolol appears to reduce symptomatic ischemia better
than verapamil, but no difference in silent ischemia and unfavourable out-
comes was seen. SI is common (34%) in UA despite heparin and aspirin
therapy. Detection of Sl is related to prognosis irrespective of treatment and
may be useful for early non-invasive risk stratification.
3:15
1716-61 Nocturnal Blood Pressure and Myocardial Ischemia
in Patients with CAD
Joachim Muller, Ulrich T6nnesmann, Stefan Schaupp, Ingomar-Werner Franz.
KJinik Wehrawald, Todtmoos, Germany
Objective: It is welt known that B.P. rises during the day and decreases dur-
ing the night. However, patients with CAD have an impaired coronary flow
reserve and they may be endangered by myocardial ischemia due to a sub-
stantial reduction in nocturnal diastolic B.P. The purpose of the study was to
test this hypothesis. Methods: In 103 patients (82",21 ,?, mean age 60 ± 8
years) with documented CAD a 24-h ambulatory blood pressure monitoring
(SpaceLabs 90 202) and a 24-h Holter monitoring with ST-segment analysis
(Pathfinder V) was simultaneously performed. The patients were arbitrarily
divided into three groups with regard to their mean nocturnal diastolic B.P.
(10.00 p.m. - 6.00 a.m.): Group 1: <60 mmHg (58 ± 3) group 2: 61 - 70
mmHg (66 ± 3), group 3: 71 mmHg (78 ± 7). There were no significant differ-
ences between the three groups concerning age, sex distribution, coronary
status and therapy. ReSUlts: In group 1 86.2% of the patients had noctur-
nal episodes of ST-segment depression compared with 50% of group 2 and
33.3% of group 3. Group 1 patients revealed a significant higher incidence
of episodes (2.7 ± 2.4/night) compared with 1.2 ± 1.8 (p < 0.01) and 0.6 ± 1
(p < 0.001) of group 2 and 3, respectively and a significant (p < 0.001) longer
duration (1608 s versus 392 sand 143 s, respectively). Group 1 patients had a
significantly greater reduction in nocturnal diastolic B.P. with 14.3 ± 6 mmHg
compared with 11.5 ± 6 mmHg (p < 0.05) and 6.6 ± 5 mmHg (p < 0.001).
respectively.
Conclusions: In patients with CAD a low nocturnal diastolic B.P. profile «70
mmHg) goes along with a higher incidence and longer duration of silent is-
chemic episodes. A drop in perfusions pressure seems to be responsible
for that and should be taken into account when treating such patients with
antihypertensive or antiischemic drugs.
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1717-21 Echocardiography Can Predict Patients Who Develop
Severe Mitral Regurgitation Following Percutaneous
Mitral Balloon Valvuloplasty
Luis R. Padial, Nelmacy Freitas, Alex Sagie, Arthur Weyman, Mary Etta King,
Robert A. Levine, Igor F. Palacios. Massachusetts General Hospital, Eoston. MA
Although specific echocardiographic features of the mitral valve (MV) have
been shown to predict the likelihood of a successful outcome of percuta-
neous mitral valvuloplasty (PMV), they do not identify those patients who are
more likely to be a risk for significant mitral regurgitation (MR) post- PMV
Based on pathologic data from patients who developed severe post-PMV-
MR, an echocardiographic score was developed. (MR-Echo Score) which
included uneven distribution of thickness and calcification of both mitral
leaflets, degree of commissural disease and subvalvular involvement. Each
component was graded fro 0-4 and a total score (0-16) was calculated. In-
traobserver and interobserver variability for score assessment were 6% and
7% respectively.
From 566 consecutive patients who underwent PMV, 36 (6.5%) developed
severe post-PMV MR (>3+ by angiography.) The MR-Echo Score was ap-
plied to 31 of these patients (28 women; mean age 54 + 14 yr.) for whom
pre-PMV echocardiograms were available and 31 randomly selected patients
who did not develop severe post-PMV MR but were matched for age, sex.
pre-PMV MV area and degree of MR. The total MR- Echo Score was signif-
icantly greater in the severe MR group (11.7 ± 1.9 vs. 8 ± 1.2; P < 0.001).
Using a total score ~10 as a cutoff point for predicting severe post PMV
MR. a sensitivity of 90 ± 5% and a specificity of 97 ± 3% were obtained.
Stepwise logistic regression analysis identified the MR-Echo Score as the
only independent predictor for the development of severe post-PMV MR (p
< 0.0001).
Conclusions: Specific morphologic features of the mitral valve apparatus
in mitral stenosis as identified in this new MR-Echo Score predict the devel-
opment of severe post PMV MR and therefore can be useful in the selection
of patients for PMV
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1717-31 Do All Patients Undergoing Inoue Balloon Mitral
Valvotomy Need Transesophageal Echo (TEE) to
Exclude Left Atrial Thrombus?
Jai J. Patel, Robin 8. Dyer, Ravi G. Pillay, Miroslav J. Munclinger, Abdul S. Mitha.
Cardiac Unit, Wentworth Hospital/University ofNatal, Durban, South Africa
To assess merits of TEE and transthoracic echo (TIE) to exclude left atrial
body (B) or appendage (A) thrombus IT) before valvotomy, we performed
both in 151 consecutive patients (mean age 30) with tight mitral stenosis
and NYHA 111111 disability (Group I).
Tdetected on TEE Tsuspected on TEE Confirmed Surgery No T at Surgery PMV
Ii) 5(8+ -AI 5 3 1
(III 5(AI 3 5
(liiI3(AI 3
(IV) 3(AI 2
In (i), 1 pt refused surgery and 1 had PMV after 3 mths of warfarin. In liv), 2
pts had PMV and 1 no procedure. Thus 10.5% pts showed thrombus on TEE;
of these 81 % were in AF and 3 were in SR. Following on this experience, the
next 165 similar consecutive pts had TEE before PMVonly if Twas suspected
on TIE. Group II:
Alll1 pts in (ii) with TEE thrombus had uneventful PMV Thus only 16% had
TEE. Of 38 pts having PMV without TEE, minor embolic episodes occurred
in 3. All 3 had no evidence of T on post event TEE.
Conclusion: In young pts carefully performed TIE is a useful screening
procedure before PMV TEE is not mandatory and should be performed if T
suspected on TIE to exclude left atrial body thrombus as Inoue PMV IS safe
in presence of appendage thrombus.
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1717-1 I Elevated Left Ventricular End-Diastolic Pressure in
Mitral Stenosis: Reduction After Valvuloplasty
Roderick J. Sawyer, John D. Carroll, Ted Feldman, Thomas N. Levin, Gerald Dorms,
North American Inoue Investigators. The University of Chicago Hospital, Chicago, IL
Traditionally, an elevated LVEDP in mitral stenosis has implied coexistent aor-
tic valve disease, coronary artery disease, or myocardial disease and has
been a predictor of poor outcome after mitral valvuloplasty (BMV). We first
examined our local population of BMV (n = 77) and found that aortic and
coronary disease did not account for the elevated LVEDP in the majority of
patients. Secondly, we examined the Inoue BMV database. Group I (n = 844)
had pre-BMV LVEDP ~ 15 mmHg while group II (n = 200) had an LVEDP > 15
mmHg. After BMV a rise in LVEDP occurred in group I (pre: 9.9 ± 3.3 mmHg
vs post: 12.5 ± 8.6 mmHg, p < 0.05) as well as a decrease in mean LAP from
23 mmHg to 17 mmHg, p < 0.05). In contrast, group II had a fait in LVEDP
(pre: 22.7 ± 15.2 mmHg vs post: 19.8 ± 11.4 mmHg, p < 0.05) as well as a
decrease in LAP (28 mmHg to 24 mmHg, p < 0.01).
A subgroup studied at six months post-BMV revealed no change in group
I (n ~ 105) LVEDP (post: 11.5 ± 5.4 mmHg vs 11.8 ± 4.7 mmHg, p = NS)
while group II (n = 22) had a progressive fall (post: 19.9 ± 4.8 mmHg vs 13.8
± 3.8 mmHg, p < 0.01). There was no correlation between NYHA class at
six months and the pre or post BMV LVEDP.
Conclusion: An increased baseline LVEDP in mitral stenosis is not a pre-
dictor of poor outcome after mitral valvuloplasty. The fait of LVEDP supports
the claim that BMV improves LV chamber compliance perhaps by untether-
ing the restricted LV
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